株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のバイオシミラー市場の分析

Analysis of the Global Biosimilars Market

発行 Frost & Sullivan 商品コード 293861
出版日 ページ情報 英文 380 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
世界のバイオシミラー市場の分析 Analysis of the Global Biosimilars Market
出版日: 2014年01月16日 ページ情報: 英文 380 Pages
概要

差し迫った特許失効、次世代のバイオシミラー(バイオ後続品)のパイプラインが、成長の原動力になっています。

当レポートでは、世界のバイオシミラー市場について調査分析し、地域の市場普及率と市場力学に焦点を当てて、市場概要、市場エンジニアリング評価、収益予測、競合分析、市場/セグメント別の主要動向を提供して、概略以下の構成でお届けいたします。

本調査で扱っている内容

  • 世界のバイオシミラー市場の現在のシナリオは?いつまで続く見通しか?
  • 市場の主な促進要因は?解決すべき障壁は?
  • 注目すべき市場セグメントは?主要動向と規制面はどうなっているか?
  • 主な市場参入企業は?地域は?
  • 欧州の地域別の市場に影響を与える要因は?
  • 将来のバイオシミラー市場のシナリオは?市場で成功するために参入企業がすべきことは?

目次

  • エグゼクティブサマリー
  • 市場概要
  • 競合情勢
  • 促進要因、抑制要因、動向:総合市場
  • 予測と動向:総合市場
  • 競合環境
  • 注目すべき主要企業
  • 欧州市場
  • 欧州:エリスロポエチン
  • 欧州:顆粒球コロニー刺激因子
  • 欧州:ヒト成長ホルモン
  • 欧州:インスリン
  • 欧州:モノクローナル抗体
  • 欧州:インターフェロン
  • 英国市場
  • ドイツ市場
  • フランス市場
  • イタリア市場
  • スペイン市場
  • ベネルクス市場
  • スカンジナビア市場
  • 米国市場
  • 米国:エリスロポエチン
  • 米国:顆粒球コロニー刺激因子
  • 米国:ヒト成長ホルモン
  • 米国:インスリン
  • 米国:モノクローナル抗体
  • 米国:インターフェロン
  • 中国市場
  • 中国:エリスロポエチン
  • 中国:顆粒球コロニー刺激因子
  • 中国:ヒト成長ホルモン
  • 中国:インスリン
  • 中国:モノクローナル抗体
  • 中国:インターフェロン
  • インド市場
  • 韓国市場
  • 日本市場
  • オーストラリア市場
  • ラテンアメリカ市場
  • ラテンアメリカ:エリスロポエチン
  • ラテンアメリカ:顆粒球コロニー刺激因子
  • ラテンアメリカ:ヒト成長ホルモン
  • ラテンアメリカ:インスリン
  • ラテンアメリカ:モノクローナル抗体
  • ラテンアメリカ:インターフェロン
  • ブラジル市場
  • メキシコ市場
  • アルゼンチン市場
  • まとめ
  • 付録

図表

目次
Product Code: M95E-01-00-00-00

Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth

Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market. The research service provides analysis on regional market penetration and market dynamics. This study also provides a market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the biosimilars market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia as well as Asia-Pacific and Latin America. The study period is 2009-2019, with 2012 as the base year.

Key Questions This Study Will Answer

  • What is the current scenario of the global biosimilars market, and how far will it go?
  • What are the key factors driving the market, and what are the barriers that need to be resolved?
  • Which are the key market segments to look out for, and what are the key trends and regulatory aspects?
  • Who are the key market participants involved, and where do they stand?
  • What are the factors affecting the biosimilars market in different regions of Europe, and how will these factors affect the market in the future?
  • What is the future biosimilars market scenario, and what should market participants do to succeed?

Table of Contents

1. Executive Summary

  • Key Findings
  • Scope and Segmentation
  • Key Questions This Study Will Answer
  • Market Engineering Measurements
  • CEO's Perspective
  • Key Companies to Watch
  • Executive Summary-3 Big Predictions

2. Market Overview

  • Comparative Analysis: Generics, Biosimilars, and Biologics
  • Market Segmentation
  • Geographic Perspective
  • Timeline of Key Events
  • Biosimilar Trends in the Future

3. Competitive Playbook

  • New Market Opportunities
  • Merger, Acquisition, and Partnership Assessment

4. Drivers, Restraints, and Trends-Total Biosimilars Market

  • Market Drivers
  • Market Restraints
  • Impact Mapping of Drivers and Restraints

5. Forecasts and Trends-Total Biosimilars Market

  • Market Engineering Measurements
  • Forecast Assumptions and Definitions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Percent Revenue Forecast by Region
  • Revenue Forecast by Region
  • Emerging Trends-Biobetters

6. Competitive Environment

  • Competitive Landscape Analysis
  • Pipeline Analysis
  • Market Share Analysis-Global

7. Key Companies to Watch

  • Companies to Watch

8. Europe Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Market Analysis
  • Pricing Analysis
  • Pricing Trends and Forecast
  • PEST Analysis
  • Market Share Analysis
  • Marketed Product Analysis
  • Biologics Patent Expiry Analysis
  • Patent Expirations

9. Europe Erythropoietin Segment Breakdown

10. Market Overview

  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Regulatory Environment-Europe EPO Biosimilars

11. Europe Granulocyte Colony Stimulating Factors Segment Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Regulatory Environment-Europe G-CSF Biosimilars

12. Europe Human Growth Hormone Segment Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Regulatory Environment-Europe HGH Biosimilars

13. Europe Insulin Segment Breakdown

  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion
  • Regulatory Environment-Europe Insulin Biosimilars

14. Europe Monoclonal Antibodies Segment Breakdown

  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion
  • Regulatory Environment-Europe mAbs Biosimilars

15. Europe Interferons Segment Breakdown

  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion
  • Regulatory Environment-Europe Interferon Biosimilars

16. The United Kingdom Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

17. Germany Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

18. France Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

19. Italy Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

20. Spain Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

21. Benelux Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

22. Scandinavia Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

23. The United States Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Pricing Analysis
  • PEST Analysis
  • Biologics Patent Expiry Analysis
  • Patent Expirations

24. The United States Erythropoietin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

25. The United States Granulocyte Colony Stimulating Factors Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

26. The United States Human Growth Hormone Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Trends and Forecast
  • Pricing Trends and Forecast Discussion

27. The United States Insulin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

28. The United States Monoclonal Antibodies Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

29. The United States Interferons Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Trends and Forecast
  • Pricing Trends and Forecast Discussion

30. China Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • PEST Analysis
  • Regulatory Environment
  • Market Share Analysis

31. China Erythropoietin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

32. China Granulocyte Colony Stimulating Factors Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

33. China Human Growth Hormone Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

34. China Insulin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

35. China Monoclonal Antibodies Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Local Market Participants

36. China Interferons Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

37. India Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • PEST Analysis

38. South Korea Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Reimbursement System and Pricing Analysis
  • PEST Analysis
  • Marketed Product Analysis
  • Pipeline Analysis

39. Japan Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Pricing Analysis
  • Pricing Trends and Forecast
  • PEST Analysis
  • Product Analysis

40. Australia Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Pricing Analysis
  • Pricing Trends and Forecast
  • PEST Analysis

41. Latin America Breakdown

  • Market Overview-Biosimilars
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Pricing Analysis
  • Pricing Trends and Forecast
  • Pricing Trends and Forecast Discussion
  • PEST Analysis
  • Competitive Analysis

42. Latin America Erythropoietin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

43. Latin America Granulocyte Colony Stimulating Factors Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

44. Latin America Human Growth Hormone Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

45. Latin America Insulin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

46. Latin America Monoclonal Antibodies Segment Breakdown

  • Market Overview

47. Latin America Interferons Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

48. Brazil Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis

49. Mexico Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis

50. Argentina Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis

51. The Last Word

  • The Last Word-3 Big Predictions
  • The Last Word-Discussion
  • Legal Disclaimer

52. Appendix

  • Market Overview
  • Market Definitions
  • Market Background
  • Drivers Explained
  • Restraints Explained
  • Market Engineering Methodology
  • Learn More-Next Steps
  • Decision Support Databases

List of Exhibits

  • Total Biosimilars Market: Market Engineering Measurements, Global, 2012
  • Comparative Analysis: Generics, Biosimilars, and Biologics, Global, 2012
  • Total Biosimilars Market: Market Segmentation, Global, 2012
  • Total Biosimilars Market: Percent Revenue by Geographic Region, Global, 2012
  • Total Biosimilars Market: Timeline of Key Events, Global, 2012 and 2013
  • Total Biosimilars Market: Market Outlook, Global, 2012 and 2022
  • Total Biosimilars Market: Game-changing Strategies, Global, 2012
  • Total Biosimilars Market: Market Outlook, Global, 2012
  • Total Biosimilars Market: Key Market Drivers, Global, 2013-2019
  • Total Biosimilars Market: Key Market Restraints, Global, 2013-2019
  • Total Biosimilars Market: Impact Mapping of Drivers and Restraints, Global, 2013-2019
  • Total Biosimilars Market: Market Engineering Measurements, Global, 2012
  • Total Biosimilars Market: Revenue Forecast, Global, 2009-2019
  • Total Biosimilars Market: Percent Revenue Forecast by Region, Global, 2009-2017
  • Total Biosimilars Market: Revenue Forecast by Region, Global, 2009-2019
  • Total Biosimilars Market: Competitive Landscape Analysis, Global, 2012
  • Total Biosimilars Market: Pipeline Analysis, Global, 2012
  • Total Biosimilars Market: Competitive Landscape, Global, 2012
  • Total Biosimilars Market: Percent Sales Breakdown, Global, 2012
  • Total Biosimilars Market: Company Market Share Analysis of Top 5 Participants, Global, 2012
  • Biosimilars Market: Key Stake Holders, Europe, 2012
  • Biosimilars Market: Market Engineering Measurements, Europe, 2012
  • Biosimilars Market: Revenue Forecast, Europe, 2009-2019
  • Biosimilars Market: Pricing Analysis, Europe, 2012
  • Biosimilars Market: Time from Marketing Authorisation to Price Approval, Europe, 2012
  • Biosimilars Market: Average Price for EPO, Europe, 2009-2019
  • Biosimilars Market: Average Price for G-CSF, Europe, 2009-2019
  • Biosimilars Market: Average Price for HGH, Europe, 2009-2019
  • Biosimilars Market: PEST Analysis, Europe, 2012
  • Biosimilars Market: Percent of Sales, Europe, 2012
  • Biosimilars Market: Company Market Share Analysis of Top 5 Participants, Europe, 2012
  • Biosimilars Market: Ranking of Key Participants Based on Market Share, Europe, 2012
  • Biosimilars Market: Competitive Landscape, Europe, 2012
  • Biosimilars Market: Marketed Product Analysis, Europe, 2012
  • Biologics Market: Patent Expiry Analysis, Europe, 2012
  • Biologics Market: Patent Expirations, Europe, 2000-2030
  • EPO Segment: Market Engineering Measurements, Europe, 2012
  • EPO Segment: Revenue Forecast, Europe, 2009-2019
  • G-CSF Segment: Market Engineering Measurements, Europe, 2012
  • G-CSF Segment: Revenue Forecast, Europe, 2009-2019
  • HGH Segment: Market Engineering Measurements, Europe, 2012
  • HGH Market: Revenue Forecast, Europe, 2009-2019
  • Insulin Segment: Scenario Revenue Forecast, Europe 2015-2019
  • mAbs Segment: Scenario Revenue Forecast, Europe 2015-2019
  • Interferons Segment: Scenario Revenue Forecast, Europe 2015-2019
  • Biosimilars Market: Market Engineering Measurements, UK, 2012
  • Biosimilars Market: Revenue Forecast, UK, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Germany, 2012
  • Biosimilars Market: Revenue Forecast, Germany, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, France, 2012
  • Biosimilars Market: Revenue Forecast, France, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Italy, 2012
  • Biosimilars Market: Revenue Forecast, Italy, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Spain, 2012
  • Biosimilars Market: Revenue Forecast, Spain, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Benelux, 2012
  • Biosimilars Market: Revenue Forecast, Benelux, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Scandinavia, 2012
  • Biosimilars Market: Revenue Forecast, Scandinavia, 2009-2019
  • Biosimilars Market: Revenue Forecast, US, 2009-2019
  • Biosimilars Market: Revenue Forecast Comparison between Branded Biologics and Biosimilars, US, 2009-2019
  • Biosimilars Market: Timeline of Biosimilars Regulatory Activity, US, 2012
  • Biosimilars Market: Overview of Application Requirements for Biosimilars, US, 2012
  • Biosimilars Market: Biosimilars User Fee Act Fee Structure, US, 2012
  • Biosimilars Market: Pricing Analysis, US, 2012
  • Biosimilars Market: PEST Analysis, US, 2012
  • Biologics Market: Patent Expiry Analysis, US, 2012
  • Biologics Market: Patent Expirations, US, 2000-2030
  • EPO Segment: Revenue Forecast, US, 2009-2019
  • EPO Segment: Scenario Revenue Forecast, US, 2009-2019
  • EPO Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • EPO Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • EPO Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • G-CSF Segment: Revenue Forecast, US, 2009-2019
  • G-CSF Segment: Scenario Revenue Forecast, US, 2009-2019
  • G-CSF Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • G-CSF Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • G-CSF Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • HGH Segment: Revenue Forecast, US, 2009-2019
  • HGH Segment: Revenue Forecast Comparison Between Branded Biologics and Biosimilars, US, 2009-2019
  • HGH Segment: Annual Cost of Therapy, US, 2009-2019
  • HGH Segment: ACT Comparison Between Branded Biologics and Biosimilars, US, 2009-2019
  • Insulin Segment: Revenue Forecast, US, 2009-2019
  • Insulin Segment: Scenario Revenue Forecast, US, 2009-2019
  • Insulin Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • Insulin Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • Insulin Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • mAbs Segment: Revenue Forecast, US, 2009-2019
  • Biosimilars Market: Marketed mAbs at Risk for Biosimilar Competition, US, 2012
  • mAbs Segment: Scenario Revenue Forecast, US, 2015-2019
  • mAbs Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • mAbs Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • mAbs Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • Interferons Segment: Revenue Forecast, US, 2009-2019
  • Interferons Segment: Annual Cost of Therapy, US, 2009-2019
  • Interferons Segment: ACT Comparison Between Branded Biologics and Biosimilars, US, 2009-2019
  • Biosimilars Market: Revenue Forecast, China, 2009-2019
  • Biosimilars Market: PEST Analysis, China,2012
  • Biosimilars Market: Percent of Sales, China, 2012
  • EPO Segment: Revenue Forecast, China, 2009-2019
  • EPO Segment: Pricing Analysis, China, 2012
  • G-CSF Segment: Revenue Forecast, China, 2009-2019
  • G-CSF Segment: Pricing Analysis, China, 2012
  • HGH Segment: Revenue Forecast, China, 2009-2019
  • HGH Segment: Pricing Analysis, China, 2012
  • Insulin Segment: Revenue Forecast, China, 2009-2019
  • Insulin Segment: Pricing Analysis, China, 2012
  • mABs Segment: Revenue Forecast, China, 2009-2019
  • Interferons Segment: Revenue Forecast, China, 2009-2019
  • Interferons Segment: Pricing Analysis, China, 2012
  • Biosimilars Market: Revenue Forecast, India, 2009-2019
  • Biosimilars Market: PEST Analysis, India, 2012
  • Biosimilars Market: Revenue Forecast, South Korea, 2009-2019
  • Biosimilars Market: Regulatory Guidelines, South Korea, 2012
  • Biosmilar Market: PEST Analysis, South Korea, 2012
  • Biosimilars Market: Pipeline Analysis, South Korea, 2012
  • Biosimilars Market: Revenue Forecast, Japan, 2009-2019
  • Biosimilars Market: Regulatory Guidelines, Japan, 2012
  • Biosimilars Market: Pricing Analysis, Japan, 2012
  • Biosimilars Market: Average Price for G-CSF, Japan, 2009-2019
  • Biosimilars Market: Average Price for EPO, Japan, 2009-2019
  • Biosimilars Market: PEST Analysis, Japan, 2012
  • Biosimilars Market: Product Analysis, Japan, 2012
  • Biosimilars Market: Revenue Forecast, Australia, 2009-2019
  • Biosimilars Market: Pricing Analysis, Australia, 2012
  • Biosimilars Market: PEST Analysis, Australia, 2012
  • Biosimilars Market: Revenue Breakdown by Segment, Latin America, 2012
  • Biosimilars Market: Revenue Forecast, Latin America, 2009-2019
  • Biosimilars Market: Pricing Analysis, Latin America, 2012
  • Biosimilars Market: Average Price for G-CSF, Latin America, 2009-2019
  • Biosimilars Market: Average Price for HGH, Latin America, 2009-2019
  • Biosimilars Market: Average Price for Insulin, Latin America, 2009-2019
  • Biosimilars Market: Average Price for Interferons, Latin America, 2009-2019
  • Biosimilars Market: PEST Analysis, Latin America, 2012
  • Biosimilars Market: Top Biosimilar Companies by Rank, Latin America, 2012
  • EPO Segment: Revenue Forecast, Latin America, 2009-2019
  • G-CSF Segment: Revenue Forecast, Latin America, 2009-2019
  • HGH Segment: Revenue Forecast, Latin America, 2009-2019
  • Insulin Segment: Revenue Forecast, Latin America, 2009-2019
  • Interferons Segment: Revenue Forecast, Latin America, 2009-2019
  • Biosimilars Market: Revenue Forecast, Brazil, 2009-2019
  • Biosimilars Market: Revenue Forecast, Mexico, 2009-2019
  • Biosimilars Market: Revenue Forecast, Argentina, 2009-2019
  • Total Biosimilars Market: Pharma Industry and Biosimilar Trends Market, Global, 2012
  • Pharmaceutical and Biotech Industry: Revenue Forecast, Global, 2009-2019
  • Decision Support Database: Total Pharmaceutical Market, Global, 2008-2018
  • Decision Support Database: Pharmaceutical R&D Expenditure, Global, 2008-2018
  • Decision Support Database: Number of Biotech Companies, Global, 2008-2018
  • Decision Support Database: Government R&D Expenditure in Biotechnology, Global, 2008-2018
  • Decision Support Database: Venture Capital Investment in Biotech R&D, Global, 2008-2018
Back to Top